Geron reported $97.49M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Amgen AMGN:US $ 916M 5784M
Bio Techne TECH:US $ 1714.38M 11.39M
Cti Biopharma CTIC:US $ -27.92M 31.68M
Cytokinetics CYTK:US $ 116.26M 127.6M
Esperion Therapeutics ESPR:US $ -249040000 52.1M
Exelixis EXEL:US $ 2293.85M 83.24M
Genmab GEN:DC DK 22719M 523M
Geron GERN:US $ 97.49M 28.93M
Gilead Sciences GILD:US $ 19927M 1142M
Macrogenics MGNX:US $ 178.21M 61.4M
Novartis NOVN:VX SF 61540M 6115M
Novavax NVAX:US $ 65.32M 417M
Pain Therapeutics PTIE:US $ 237.09M 16.82M
Seattle Genetics SGEN:US $ 2998.47M 66.67M
YTE INCY:US $ 3863.07M 93.07M